Who is sponsoring NCT04041089?

NCT04041089 is sponsored by Centre Hospitalier Universitaire de Nice.

What drugs are being tested in NCT04041089?

Interventions in NCT04041089: Recognition of objects, Location of objects, Manipulation of objects.

What condition does NCT04041089 study?

NCT04041089 studies Posterior Cortical Atrophy.

Is NCT04041089 still recruiting?

NCT04041089 is currently completed. Last updated 22 March 2023.

Last reviewed 2023-03-22 · How we verify

NCT04041089: REEDUC-ACP

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Development of the Effectiveness of Rehabilitation Tools for Neurovisual Disorders in Patients With Posterior Cortical Atrophy

Completed NA Last updated 22 March 2023

What this trial tests

NA trial testing Recognition of objects in Posterior Cortical Atrophy in 3 participants. Completed in 15 June 2022.

Timeline

2 September 2019

Primary endpoint
15 June 2021

15 June 2022

Quick facts

Lead sponsor	Centre Hospitalier Universitaire de Nice
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	3
Start date	2 September 2019
Primary completion	15 June 2021
Estimated completion	15 June 2022
Sites	1 location across France

Drugs / interventions tested

Recognition of objects
Location of objects
Manipulation of objects

Conditions studied

Posterior Cortical Atrophy — all drugs for Posterior Cortical Atrophy →

Sponsor

Centre Hospitalier Universitaire de Nice

Who can join

50 and older, any sex, with Posterior Cortical Atrophy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Posterior cortical atrophy (PCA) is manifested by neuro-visual disorders that alter the spatial location of objects, their manipulation and/or recognition. Its etiology is most often neurodegenerative, with a major impact on the autonomy and mood of patients and their families. Few studies have focused on non-medication management of these disorders. The present study thus has a double objective: the development of a complete tool to work on the recognition, localization and/or manipulation of objects; and the evaluation of the effectiveness of this type of management.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Centre Hospitalier Universitaire de Nice trials

Trials by the same sponsor.

NCT05897996 — Percutaneous Anastomosis Creation for Hemodialysis Access · NA · withdrawn
NCT07499869 — INNOVATIVE BENEFITS OF A 4D VIRTUAL SIMULATOR · NA · not yet recruiting
NCT07492251 — Upadacitinib in Adult Patients With Erosive Mucosal Lichen Planus and Lichen Planopilaris: a Prospective Multicenter Ran · Phase 2 · not yet recruiting
NCT07511608 — Development of a New Technique for Quantifying Mitochondrial DNA in Single Muscle Fibers · NA · not yet recruiting
NCT07582406 — Codesign, Physical Activity, and Seniors · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04041089 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier Universitaire de Nice
Last refreshed: 22 March 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04041089.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing